ArticleInternational journal of molecular medicine2025

Cynarin as a potent anti‑osteolytic agent: Targeting MAPK and Nrf2‑Keap1 pathways for osteoclast inhibition and bone protection.

Rui Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.